195 Intraprostatic Injection of Botulinum Toxin-A in Patients With Refractory Chronic Pelvic Pain Syndrome: The Transurethral vs. Transrectal Approach

Journal of Sexual Medicine - United States
doi 10.1016/j.jsxm.2017.11.154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Botulinum Toxin Type a (BOTOX) for Refractory Myofascial Pelvic Pain

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
2014English

Bilateral Thyroarytenoid Botulinum Toxin Type a Injection for the Treatment of Refractory Chronic Cough

JAMA Otolaryngology - Head and Neck Surgery
MedicineOtorhinolaryngologySurgery
2016English

A Comparative Study Between Sacral Neuromodulation and Intravesical Botulinum Toxin Injection for Patients With Refractory Overactive Bladder

Arab Journal of Urology
Urology
2020English

The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial

Contemporary Clinical Trials
MedicinePharmacology
2014English

Management of Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: «second-Line» Therapy Possibilities

Urology Herald
2019English

Botulinum Toxin a for the Management of Interstitial Cystitis/Bladder Pain Syndrome

Herald Urology
2017English

Management of Chronic Prostatitis/ Chronic Pelvic Pain Syndrome

JAMA - Journal of the American Medical Association
Medicine
2011English

Therapy-Related Longitudinal Brain Perfusion Changes in Patients With Chronic Pelvic Pain Syndrome

Swiss Medical Weekly
Medicine
2017English

Mechanisms in Prostatitis/Chronic Pelvic Pain Syndrome

Journal of Urology
Urology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy